Researcher.Life Logo

Clinical Drug Investigation : Impact Factor & More

eISSN: 1179-1918pISSN: 1173-2563

Key Metrics

CiteScore
5.2
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Drug Investigation

Clinical Drug Investigation Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Drug Investigation ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Drug Investigation

Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials.
  • 25 Nov 2025
  • Clinical drug investigation
Acknowledgement to Referees and the Editorial Board.
  • 17 Nov 2025
  • Clinical drug investigation
Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions.
  • 12 Nov 2025
  • Clinical drug investigation
Bumetanide Nasal Spray: First Approval.
  • 12 Nov 2025
  • Clinical drug investigation
CT-P39: An Omalizumab Biosimilar.
  • 12 Nov 2025
  • Clinical drug investigation
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System.
  • 8 Nov 2025
  • Clinical drug investigation
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials.
  • 25 Nov 2025
  • Clinical drug investigation
Acknowledgement to Referees and the Editorial Board.
  • 17 Nov 2025
  • Clinical drug investigation
Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions.
  • 12 Nov 2025
  • Clinical drug investigation
Bumetanide Nasal Spray: First Approval.
  • 12 Nov 2025
  • Clinical drug investigation
CT-P39: An Omalizumab Biosimilar.
  • 12 Nov 2025
  • Clinical drug investigation
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System.
  • 8 Nov 2025
  • Clinical drug investigation

FAQs on Clinical Drug Investigation